-
1
-
-
0025902106
-
Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease
-
Milne RJ, Buckley MM. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease. Drugs 1991;41:941-69.
-
(1991)
Drugs
, vol.41
, pp. 941-969
-
-
Milne, R.J.1
Buckley, M.M.2
-
2
-
-
0023617391
-
Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris
-
Riddel JG, Shanks RG, Brogden RN. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris. Drugs 1987;34:438-58.
-
(1987)
Drugs
, vol.34
, pp. 438-458
-
-
Riddel, J.G.1
Shanks, R.G.2
Brogden, R.N.3
-
3
-
-
0027146389
-
Transport of celiprolol across human intestinal epithelial (Caco-2) cells: Mediation of secretion by multiple transporters including P-glycoprotein
-
Karlsson J, Kuo S-M, Ziemniak J, Artursson P. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Br J Pharmacol 1993;110:1009-16.
-
(1993)
Br J Pharmacol
, vol.110
, pp. 1009-1016
-
-
Karlsson, J.1
Kuo, S.-M.2
Ziemniak, J.3
Artursson, P.4
-
4
-
-
0025782262
-
Reversal of daunorubicin resistance in P388/ADR cells by itraconazole
-
Gupta S, Kim J, Gollapudi S. Reversal of daunorubicin resistance in P388/ADR cells by itraconazole. J Clin Invest 1991;87:1467-9.
-
(1991)
J Clin Invest
, vol.87
, pp. 1467-1469
-
-
Gupta, S.1
Kim, J.2
Gollapudi, S.3
-
8
-
-
0030982634
-
Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression
-
Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545-53.
-
(1997)
J Clin Invest
, vol.99
, pp. 2545-2553
-
-
Lown, K.S.1
Bailey, D.G.2
Fontana, R.J.3
Janardan, S.K.4
Adair, C.H.5
Fortlage, L.A.6
-
9
-
-
0031790854
-
Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells
-
Takanaga H, Ohnishi A, Matsuo H, Sawada Y. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol Pharm Bull 1998;21:1062-6.
-
(1998)
Biol Pharm Bull
, vol.21
, pp. 1062-1066
-
-
Takanaga, H.1
Ohnishi, A.2
Matsuo, H.3
Sawada, Y.4
-
10
-
-
0032865554
-
Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components
-
Eagling VA, Profit L, Back DJ. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br J Clin Pharmacol 1999;48:543-52.
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 543-552
-
-
Eagling, V.A.1
Profit, L.2
Back, D.J.3
-
11
-
-
0034751938
-
Effect of grapefruit juice on digoxin pharmacokinetics in humans
-
Becquemont L, Verstuyft C, Kerb R, Brinkmann U, Lebot M, Jaillon P, et al. Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin Pharmacol Ther 2001;70:311-6.
-
(2001)
Clin Pharmacol Ther
, vol.70
, pp. 311-316
-
-
Becquemont, L.1
Verstuyft, C.2
Kerb, R.3
Brinkmann, U.4
Lebot, M.5
Jaillon, P.6
-
12
-
-
0036159433
-
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
-
Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71:11-20.
-
(2002)
Clin Pharmacol Ther
, vol.71
, pp. 11-20
-
-
Dresser, G.K.1
Bailey, D.G.2
Leake, B.F.3
Schwarz, U.I.4
Dawson, P.A.5
Freeman, D.J.6
-
13
-
-
0033982692
-
R&D biochemistry and separation, Merck KgaA: A new monolithic-type HPLC column for fast separations
-
Cabrera K, Lubda D, Eggenweiler H-M, Minakuchi H, Nakanishi K. R&D biochemistry and separation, Merck KgaA: a new monolithic-type HPLC column for fast separations. J High Resolut Chromatogr 2000;23:93-9.
-
(2000)
J High Resolut Chromatogr
, vol.23
, pp. 93-99
-
-
Cabrera, K.1
Lubda, D.2
Eggenweiler, H.-M.3
Minakuchi, H.4
Nakanishi, K.5
-
14
-
-
0030582640
-
Validated assay for the determination of celiprolol in plasma using high-performance liquid chromatography and a silanol deactivated reversephase support
-
Chiu FCK, Raymond K. Validated assay for the determination of celiprolol in plasma using high-performance liquid chromatography and a silanol deactivated reversephase support. J Chromatogr B 1996;687:462-5.
-
(1996)
J Chromatogr B
, vol.687
, pp. 462-465
-
-
Chiu, F.C.K.1
Raymond, K.2
-
15
-
-
0025049990
-
Determination of itraconazole in serum with high-performance liquid chromatography and fluorescence detection
-
Allenmark S, Edebo A, Lindgren K. Determination of itraconazole in serum with high-performance liquid chromatography and fluorescence detection. J Chromatogr 1990;532:203-6.
-
(1990)
J Chromatogr
, vol.532
, pp. 203-206
-
-
Allenmark, S.1
Edebo, A.2
Lindgren, K.3
-
16
-
-
0023787266
-
Assay of itraconazole in leukemic patient plasma by reversed-phase small-bore liquid chromatography
-
Remmel RP, Dombrovskis D, Canafax DM. Assay of itraconazole in leukemic patient plasma by reversed-phase small-bore liquid chromatography. J Chromatogr 1988;432:388-94.
-
(1988)
J Chromatogr
, vol.432
, pp. 388-394
-
-
Remmel, R.P.1
Dombrovskis, D.2
Canafax, D.M.3
-
17
-
-
0028303363
-
The contribution of intestinal secretion to the dose-dependent absorption of celiprolol
-
Kuo SM, Whitby BR, Artursson P, Ziemniak JA. The contribution of intestinal secretion to the dose-dependent absorption of celiprolol. Pharm Res 1994;11:648-53.
-
(1994)
Pharm Res
, vol.11
, pp. 648-653
-
-
Kuo, S.M.1
Whitby, B.R.2
Artursson, P.3
Ziemniak, J.A.4
-
18
-
-
0026099498
-
Interaction of citrus juices with felodipine and nifedipine
-
Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9.
-
(1991)
Lancet
, vol.337
, pp. 268-269
-
-
Bailey, D.G.1
Spence, J.D.2
Munoz, C.3
Arnold, J.M.O.4
-
19
-
-
0031954328
-
Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid
-
Kantola T, Kivistö KT, Neuvonen PJ. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther 1998;63:397-402.
-
(1998)
Clin Pharmacol Ther
, vol.63
, pp. 397-402
-
-
Kantola, T.1
Kivistö, K.T.2
Neuvonen, P.J.3
-
20
-
-
0032421054
-
Grapefruit juice substantially increases plasma concentrations of buspirone
-
Lilja JJ, Kivistö KT, Backman JT, Lamberg TS, Neuvonen PJ. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther 1998;64:655-60.
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 655-660
-
-
Lilja, J.J.1
Kivistö, K.T.2
Backman, J.T.3
Lamberg, T.S.4
Neuvonen, P.J.5
-
21
-
-
0242645646
-
Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin
-
Lilja JJ, Kivistö KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin Pharmacol Ther 1999;66:118-27.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 118-127
-
-
Lilja, J.J.1
Kivistö, K.T.2
Neuvonen, P.J.3
-
22
-
-
0031966729
-
Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance
-
Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf 1998;18:251-72.
-
(1998)
Drug Saf
, vol.18
, pp. 251-272
-
-
Fuhr, U.1
-
23
-
-
0036159434
-
Effects of grapefruit juice on the pharmacokinetics of sildenafil
-
Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, Hering U, Bulitta J, Schreiner P, et al. Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 2002;71:21-9.
-
(2002)
Clin Pharmacol Ther
, vol.71
, pp. 21-29
-
-
Jetter, A.1
Kinzig-Schippers, M.2
Walchner-Bonjean, M.3
Hering, U.4
Bulitta, J.5
Schreiner, P.6
-
24
-
-
1442321728
-
6′,7′-Dihydroxybergamottin in grapefruit juice and Sevilla orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein
-
Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, et al. 6′,7′-Dihydroxybergamottin in grapefruit juice and Sevilla orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 1999;65:237-44.
-
(1999)
Clin Pharmacol Ther
, vol.65
, pp. 237-244
-
-
Edwards, D.J.1
Fitzsimmons, M.E.2
Schuetz, E.G.3
Yasuda, K.4
Ducharme, M.P.5
Warbasse, L.H.6
-
25
-
-
0032793959
-
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
-
Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999;27:866-71.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 866-871
-
-
Cvetkovic, M.1
Leake, B.2
Fromm, M.F.3
Wilkinson, G.R.4
Kim, R.B.5
-
26
-
-
0036091282
-
Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine
-
Banfield C, Gupta S, Marino M, Lim J, Affrime M. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet 2002;41:311-8.
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 311-318
-
-
Banfield, C.1
Gupta, S.2
Marino, M.3
Lim, J.4
Affrime, M.5
|